Indaptus Therapeutics, Inc. (NASDAQ:INDP – Get Free Report) major shareholder Glen R. Anderson acquired 23,934 shares of the business’s stock in a transaction on Monday, August 14th. The stock was purchased at an average cost of $2.34 per share, with a total value of $56,005.56. Following the acquisition, the insider now directly owns 1,190,400 shares […]